CXSL2300015 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products(3.3) | New Drug Application | 2023-01-06 | | Nanjing Zhengda Tianqing Pharmaceutical Co Ltd | | | view |
CXSL2500356 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products(3.3) | New Drug Application | 2025-05-08 | | Nanjing Zhengda Tianqing Pharmaceutical Co Ltd | | | view |
CXSL2500357 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products(3.3) | New Drug Application | 2025-05-08 | | Nanjing Zhengda Tianqing Pharmaceutical Co Ltd | | | view |
JXSS2000012 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Import Drug Application | 2020-05-23 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd;Roche Pharma (Schweiz) AG;Chugai Pharma Manufacturing Co Ltd | In Review | 2021-03-30 | view |
JXSS2000013 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Import Drug Application | 2020-05-23 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd;Roche Pharma (Schweiz) AG;Chugai Pharma Manufacturing Co Ltd | In Review | 2021-03-30 | view |
JXSS2000014 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Import Drug Application | 2020-05-23 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd;Roche Pharma (Schweiz) AG;Chugai Pharma Manufacturing Co Ltd | In Review | 2021-03-30 | view |
JXSS2000015 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Import Drug Application | 2020-05-23 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd;Roche Pharma (Schweiz) AG;Chugai Pharma Manufacturing Co Ltd | In Review | 2021-03-30 | view |
JYSB1900128 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2019-06-19 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | Certificate Issued | 2019-10-17 | view |
JYSB1900129 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2019-06-19 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | Certificate Issued | 2019-10-17 | view |
JYSB1900130 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2019-06-19 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | Certificate Issued | 2019-10-17 | view |
JYSB1900131 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2019-06-19 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | Certificate Issued | 2019-10-17 | view |
JYSB1900196 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2019-08-07 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | In Review | 2019-08-06 | view |
JYSB1900197 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2019-08-07 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | In Review | 2019-08-06 | view |
JYSB1900198 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2019-08-07 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | In Review | 2019-08-06 | view |
JYSB1900199 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2019-08-07 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | In Review | 2019-08-06 | view |
JYSB1900333 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2019-12-04 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | Certificate Issued | 2020-01-22 | view |
JYSB1900334 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2019-12-04 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | Certificate Issued | 2020-01-22 | view |
JYSB1900335 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2019-12-04 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | Certificate Issued | 2020-01-22 | view |
JYSB1900336 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2019-12-04 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | Certificate Issued | 2020-01-22 | view |
JYSB2000080 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2020-03-25 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | Certificate Issued | 2020-06-10 | view |